# Novartis AG (NVS)

Novartis AG hits new 52-week and all-time highs, driven by acquisition news and strong social media buzz around drug advancements and pricing discussions.

### About Novartis AG
Novartis AG is a global pharmaceutical company.  
Novartis AG uses the ticker $NVS for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Novartis AG (NVS) Galaxy Score™ is up 29.55% from the previous week.
- Novartis AG (NVS) sentiment is up 12.33% from the previous week.
- Novartis AG (NVS) creators is up 79.46% from the previous month.
- Novartis AG (NVS) mentions is up 71.28% from the previous month.
- Novartis AG Price hit a 52-Week high of $163.40 for the hour
- Novartis AG Price hit an all time of $163.40 for the hour

### Price: $163.10
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/novartis/time-series/close.tsv)  
The stock price has reached a 52-week and all-time high, driven by positive news regarding potential drug pricing deals and the acquisition of Avidity Biosciences, supported by strong social media engagement.  

24-Hour: 1.38%
7-Day: 4.27%
30-Day: 13%

1-Year High: $163.10 on 2026-02-13  
1-Year Low: $102 on 2025-04-08  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/novartis/time-series/alt_rank.tsv)  
Novartis AG (NVS) is currently AltRank #160 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] [---]  
[--] Month: [---] [----]  
[--] Months: [---] [----]  
[--] Year: [---] [----]  
1-Year High: [-----] on 2025-06-30  
1-Year Low: [--] on 2025-07-05  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/novartis/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +13  
[--] Month: [--] [---]  
[--] Months: [--] +6  
[--] Year: [--] no change  
1-Year High: [--] on 2025-05-20  
1-Year Low: [--] on 2025-07-28  
  
  
### Engagements: [-------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/novartis/time-series/interactions.tsv)  
Current Value: [-------]  
Daily Average: [-------]  
[--] Week: [---------] -37%  
[--] Month: [----------] +254%  
[--] Months: [----------] +198%  
[--] Year: [-----------] +183%  
1-Year High: [---------] on 2025-11-28  
1-Year Low: [------] on 2026-01-11  

Engagements by network (24h):
Reddit: [---]
Instagram: [---]
TikTok: [-----]
News: [--]
YouTube: [-------]
X: [------]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/novartis/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Week: [-----] +14%  
[--] Month: [-----] +71%  
[--] Months: [------] +32%  
[--] Year: [------] +197%  
1-Year High: [-----] on 2026-02-06  
1-Year Low: [---] on 2025-07-01  

Mentions by network (24h):
Reddit: [--]
Instagram: [--]
TikTok: [--]
News: [--]
YouTube: [--]
X: [---]

  
  
### Creators: [---] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/novartis/time-series/contributors_active.tsv)  
[---] unique social accounts have posts mentioning Novartis AG (NVS) in the last [--] hours which is down 9.10% from [---] in the previous [--] hours
Daily Average: [---]  
[--] Week: [-----] +15%  
[--] Month: [-----] +79%  
[--] Months: [-----] +31%  
[--] Year: [------] +166%  
1-Year High: [---] on 2026-02-06  
1-Year Low: [---] on 2025-07-01  

The most influential creators that mention Novartis AG in the last [--] hours

| Creator                                              | Rank | Followers  | Posts | Engagements |
| -------                                              | ---- | ---------  | ----- | ----------- |
| [@upediashorts](/creator/youtube/upediashorts)       | [--]    | [----------] | [--]    | [-------]     |
| [@StockMKTNewz](/creator/twitter/StockMKTNewz)       | [--]    | [-------]    | [--]     | [------]      |
| [@theplayerstv](/creator/tiktok/theplayerstv)        | [--]    | [------]     | [--]    | [---]         |
| [@novartis011](/creator/tiktok/novartis011)          | [--]    | [--]         | [--]     | [---]         |
| [@giankos429530](/creator/twitter/giankos429530)     | [--]    | [---]        | [--]     | [---]         |
| [@theboobiedocs](/creator/tiktok/theboobiedocs)      | [--]    | [------]     | [--]     | [---]         |
| [@grok](/creator/twitter/grok)                       | [--]    | [---------]  | [--]    | [---]         |
| [@FareedZakaria](/creator/twitter/FareedZakaria)     | [--]    | [---------]  | [--]     | [---]         |
| [@Nothing04305955](/creator/twitter/Nothing04305955) | [--]    | [-----]      | [--]     | [---]         |
| [@raw_sunday](/creator/twitter/raw_sunday)           | [--]   | [-----]      | [--]     | [---]         |

[View More](/list/creators/novartis/100)
  
  
### Sentiment: 92%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/novartis/time-series/sentiment.tsv)  
Current Value: 92%  
Daily Average: 86%  
[--] Week: 82% +9%  
[--] Month: 89% +4%  
[--] Months: 89% +3%  
[--] Year: 89% -7%  
1-Year High: 98% on 2026-01-24  
1-Year Low: 22% on 2025-08-26  

Most Supportive Themes:
- WHO Partnership for Leprosy Elimination: (30%) Novartis AG's long-standing partnership with the WHO to provide free multidrug therapy for leprosy and support single-dose rifampicin.
- Acquisition of Avidity Biosciences: (30%) Novartis AG is acquiring Avidity Biosciences for $12 billion, aiming to strengthen its neuroscience pipeline.
- Pipeline Advancements: (20%) Novartis AG is presenting new treatments, including for Sjogren's disease, and has advanced its RNA therapeutics.
- Positive Financial Performance: (20%) Novartis AG reported solid sales and core operating income growth in Q3 2025, driven by new cancer medicines.
  
Most Critical Themes:
- Drug Pricing and Access Concerns: (60%) There are ongoing discussions and concerns regarding the pricing of Novartis's drug Pluvicto and patient access programs.
- Past Legal Issues: (40%) Novartis AG has faced past settlements related to kickbacks and co-pay fraud.
  
  
  
### Social Dominance: 0.038%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/novartis/time-series/social_dominance.tsv)  
Current Value: 0.038%  
Daily Average: 0.062%  
[--] Week: 0.035% -0.052%  
[--] Month: 0.054% +0.0099%  
[--] Months: 0.054% +0.0054%  
[--] Year: 0.054% -0.022%  
1-Year High: 0.143% on 2026-02-06  
1-Year Low: 0.026% on 2025-07-01  
  
  
### Market Dominance: 0.353%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/novartis/time-series/market_dominance.tsv)  
Current Value: 0.353%  
Daily Average: 7%  
1-Year High: 13.80% on 2026-02-06  
1-Year Low: 0.311% on 2025-03-14  
  
  
### Market Cap: $311,791,984,349
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/novartis/time-series/market_cap.tsv)  
Current Value: $311,791,984,349  
Daily Average: $240,722,906,710  
[--] Week: $311,791,984,349 +4.50%  
[--] Month: $311,219,538,845 +13%  
[--] Months: $311,219,538,845 +30%  
[--] Year: $311,219,538,845 +49%  
1-Year High: $311,219,538,845 on 2026-02-13  
1-Year Low: $201,380,099,726 on 2025-04-08  

### Top Novartis AG Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"am i the only one that thinks 99.99% of pharma commercials blow once Solnerva (WST-057) hits the market i will make it my lifes mission that ours dont. theyre depressing ash - fuck twin your drug is supposed to breathe life into people not suck it out. theres reasons the average American is losing trust in two things - government and big pharma. the market yearns for humor and relatability. novartis finally got it with their super bowl commercial. we will too. ours will make you laugh. you will relate and then youll put it on your insurance carriers tab. http://relaxitsabloodtest.com Gonna"  
[X Link](https://x.com/gabeviggers/status/2022747522897449304) [@gabeviggers](/creator/x/gabeviggers) 2026-02-14T18:59Z [----] followers, [---] engagements


"29 .     " " .     Novartis  .           AI  https://t.co/i5UY7lZAau           AI  https://t.co/i5UY7lZAau"  
[X Link](https://x.com/StefanoPPK/status/2022704154854953288) [@StefanoPPK](/creator/x/StefanoPPK) 2026-02-14T16:07Z [----] followers, [---] engagements


".    @AdonisGeorgiadi.   NOVARTIS     (   @atsipras)"  
[X Link](https://x.com/Nicos1270647/status/2022529453360812289) [@Nicos1270647](/creator/x/Nicos1270647) 2026-02-14T04:32Z [---] followers, [----] engagements


"@Trevornoah @Novartis @Ibra_official @IAMQUEENLATIFAH @latinomuseum @the1975 @LatinoVoices @Latincouver @Latinamd @CYDLatinxCaucus @MadridXtra @BarcelonaAtleti @NBAspain @selenagomez #_ # #OlimpiadiInvernali2026 #provadolder #RISERCONCERTDAY1 #SB19VISA We are now above [----] Please help the petition to parliament reach [-----] signatures. Have you signed https://t.co/U48eZ62K8X https://t.co/DDn03ICtav We are now above [----] Please help the petition to parliament reach [-----] signatures. Have you signed https://t.co/U48eZ62K8X https://t.co/DDn03ICtav"  
[X Link](https://x.com/kfshoa/status/2022522046727831955) [@kfshoa](/creator/x/kfshoa) 2026-02-14T04:03Z [--] followers, [---] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing